Evidence map›Paper›PMID 40567941›Full record

ArticleNeuroimage. Reports2024

Parkinsonian central pain is linked to the connectivity of the nucleus accumbens and the anterior insula.

Karel Joineau, Mathilde Boussac, Patrice Peran, David Devos, Jean Luc Houeto, Sophie Drapier, David Maltete, Jesus Aguilar, Estelle Harroch, Margherita Fabbri and 11 more

Abstract read
In one paragraph

Article in Neuroimage. Reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Karel JoineauToulouse NeuroImaging Centre (ToNIC - UMR1214 INSERM/UT3), Toulouse, France.
Mathilde BoussacToulouse NeuroImaging Centre (ToNIC - UMR1214 INSERM/UT3), Toulouse, France.
Patrice PeranToulouse NeuroImaging Centre (ToNIC - UMR1214 INSERM/UT3), Toulouse, France.
David DevosDepartment of Medical Pharmacology, Department of Neurology, Expert Center of Parkinson's Disease, Université de Lille, Lille, Lille Neuroscience and Cognition INSERM 1172, CHU de Lille NS-PARK Network, France.
Jean Luc HouetoParkinson Expert Center, Neurology Department, Limoges University Hospital, U1094 Inserm UMR270 IRD USC1501 INRAE Epidémiologie des Maladies Chroniques en Zone Tropicale EpiMaCT, Limoges, France.
Sophie DrapierDepartment of Neurology, Pontchaillou Rennes University Hospital, Clinical Investigation Center Inserm 1414, Rennes, France.
David MalteteDepartment of Neurology, Rouen University Hospital and University of Rouen, France.
Jesus AguilarDepartment of Neuroradiology, Nantes University Hospital, Nantes, France.
Estelle HarrochDepartment of Clinical Pharmacology and Neurology, University Hospital of Toulouse, Toulouse, France.
Margherita FabbriToulouse NeuroImaging Centre (ToNIC - UMR1214 INSERM/UT3), Toulouse, France.
Clémence LeungDepartment of Clinical Pharmacology and Neurology, University Hospital of Toulouse, Toulouse, France.
Fabienne Ory-MagneToulouse NeuroImaging Centre (ToNIC - UMR1214 INSERM/UT3), Toulouse, France.
Melissa TirDepartment of Neurology, Parkinson Expert Center, Amiens University Hospital, Amiens, France.
Christine TranchantNeurology Department, Strasbourg University Hospital, Strasbourg, France.
Hayet SalhiDepartment of Neurology, Parkinson Expert Center, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris, Créteil, France.
Solène FrismandDepartment of Neurology, Nancy University Hospital, Nancy, France.
Frederique FluchereDepartment of Neurology and Movement Disorders, Timone University Hospital, Assistance Publique - Hôpitaux de Marseille, France.
Ana MarquesDepartment of Neurology, CHU Clermont-Ferrand, Université Clermont-Auvergne, CNRS, ICCN, Institut Pascal, Clermont-Ferrand, NS-Park/F-CRIN Network, France.
Olivier RascolClinical Investigation Center CIC1436, Departments of Clinical Pharmacology and Neurosciences, NS-Park/FCRIN Network and NeuroToul COEN Center, University of Toulouse, INSERM and University of Toulouse 3, Toulouse, France.
Emeline DescampsToulouse NeuroImaging Centre (ToNIC - UMR1214 INSERM/UT3), Toulouse, France.
Christine Brefel-CourbonToulouse NeuroImaging Centre (ToNIC - UMR1214 INSERM/UT3), Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain is a frequent and disabling non-motor symptom of Parkinson's Disease (PD). Yet, no treatment to date can efficiently reduce this pain. This article investigates the brain functional connectivity of PD patients with central pain and the effects of levodopa and oxycodone on this connectivity. Thirty-eight PD patients received either levodopa, oxycodone, or a placebo during an eight-week period. Pain intensity was evaluated using the Visual Analogue Scale and resting-state functional connectivity was measured before and after treatments. PD patients were also separated into two groups: responders and non-responders. At baseline, the intensity of pain was correlated with the connectivity between the anterior insula and the posterior cingulate cortex and between the nucleus accumbens, the brainstem, and the hippocampus. Levodopa and oxycodone had no specific effects on functional connectivity. Responders had a decrease in connectivity between the anterior insula and the posterior cingulate cortex, while non-responders showed an increase in connectivity. The correlation between pain intensity and specific brain connectivity may represent a "hyper-awareness" of pain and a distortion of learning and memory systems in PD patients with central pain, leading to a state of chronic pain. The placebo effect could explain the changes in connectivity that are associated with a potential reduction in pain awareness.

Indexed as

Functional connectivityLevodopaOxycodonePainParkinson’s diseaseResting state

Identifiers

PMID40567941
PMCPMC12172763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.